{"prompt": "['AVANOS', 'Genicular Nerve Lesion Study', 'Confidential', 'Protocol # 105-17-0001', 'Synvisc-One has not been tested to show better pain relief when', 'A total of 253 patients in the study were assigned by chance to receive', 'combined with other injected medicines.', 'either a single injection of Synvisc-One (n=123 patients), or an injection', 'Tell your doctor if you are allergic to products from birds such as', 'of the same volume of salt water (a \"Sallne Control\" injection) (n=130', 'feathers, eggs, and poultry.', 'patients). Neither the patients nor the doctors evaluating them knew', 'Tell your doctor if you have significant swelling or blood clots in the', \"which treatment they received. Any fluid that was present in the patient's\", 'leg.', 'knee was removed before the injection. The patients were seen by their', 'Synvisc should be used with caution when there is evidence of', 'doctor at standard times over 6 months. Information was collected about', 'lymphatic or venous stasis in the leg to be injected.', 'how much pain they were experiencing doing various types of activities,', 'Synvisc-One has not been tested in pregnant women, or women', 'how much they were limited in their daily activities by their OA, and on', 'who are nursing. You should tell your doctor if you think you are', 'their overall condition. Their doctor also provided an overall rating of', 'pregnant, or if you are nursing a child.', 'their OA.', 'Synvisc-One has not been tested in children (5 21 years of age).', 'The main measure of the study was how much pain the subjects had', 'What are the risks of getting a Synvisc-One8 Injection?', 'doing five common types of activities over the 6 months duration of the', 'The side effects (also called reactions) sometimes seen after any', 'injection into the knee, including Synvisc-One, include: pain, swelling,', 'study. Daily activity limitations and overall evaluations were also com-', 'heat, redness, and/or fluid build-up around the knee. These reactions', 'pared between the group of patients receiving Synvisc-One injection and', 'are generally mild and do not last long. Reactions are generally treated', 'the group receiving salt water injection. The study showed that patients', 'by resting and applying ice to the injected knee. Sometimes it is', 'receiving Synvisc-One had significantly less pain over 6 months, and felt', 'necessary to give pain relievers by mouth such as acetaminophen or', 'significantly better than the patients who received the salt water', 'NSAIDs, or to give injections of steroids, or to remove fluid from the knee', 'injections. The difference in pain score reduction from baseline to 6', 'joint. Patients rarely undergo arthroscopy (a surgical inspection of the', 'months between the Synvisc-One and salt water control injection was', 'knee joint) or other medical procedures related to these reactions.', '0.15 out of a 5 point scale for the measurement of OA pain in the knee.', 'Other side effects seen with SYNVISC or Synvisc-One are: rashes,', 'What adverse events were observed In the clinical study?', 'hives, itching, muscle pain/cramps, flushing and/or swelling of your face,', 'The following are the most common adverse events that occurred during', 'fast heart beat, nausea (or feeling sick to your stomach), dizziness,', 'the clinical trial of Synvisc-One:', 'fever, chills, headache, difficulty breathing, swelling in your arms and/or', 'Pain in the knee or at the injection site', 'legs, prickly feeling of your skin, and in rare cases a low number of', 'Stiffness, swelling or warmth in or around the knee', 'platelets in the blood (platelets are a type of blood cell that are needed', 'to help your blood clot when you are cut or injured). Allergic reactions,', 'Changes in the way that you walk (e.g., limping)', 'some which can be potentially severe, were observed during the use of', 'Severe adverse events were not observed in the Synvisc-One trial. Joint', 'Synvisc-One.', 'infections did not occur in the injected knee in the Synvisc-One clinical', 'Rare cases of knee joint infection have been reported after SYNVISC', 'trial. The most commonly occurring adverse events outside of the', 'injections. If any of the above side effects or symptoms appear after you', 'injected knee were headache, back pain, sore throat and the flu. One', 'are given Synvisc-One, or if you have any other problems, you should', 'patient had a single episode of feeling faint.', 'call your doctor.', 'How do I get more information about the Synvisc-One product?', 'What are the benefits of getting a SynvIsc-One8 injection?', '(User Assistance)', 'As shown in a medical study of 253 patients with osteoarthritis (OA) of', 'If you have any questions or would like to find out more about', 'the knee, where approximately half received either a single injection of', 'Synvisc-One, you may call Genzyme Blosurgery at 1-888-3-SYNVISC', 'Synvisc-One or an injection of the same volume of salt water (a \"Saline', '(1-888-379-6847) or visit www.synvisc.com.', 'Control\" injection), the major benefits of Synvisc-One are pain relief and', 'improvement in other symptoms related to OA of the knee.', 'MANUFACTURED AND DISTRIBUTED BY:', 'What do I need to do after I get SynvIsc-One injection?', 'Genzyme Biosurgery', 'It is recommended you avoid strenuous activities (for example, high-', 'A division of Genzyme Corporation', 'impact sports such as tennis or jogging) or prolonged weight-bearing', '1125 Pleasant View Terrace', 'activities for approximately 48 hours following the injection. You should', 'Ridgefield, New Jersey 07657', 'consult your doctor regarding the appropriate time to resume such', 'activities.', 'SYNVISC-ONE, SYNVISC and GENZYME are registered trademarks of', 'What other treatments are available for OA?', 'Genzyme Corporation.', 'If you have OA, there are other things you can do besides getting', 'Table 1. Summary of Demographic and Baseline Characteristics', 'Synvisc-One. These include:', 'Non-drug treatments', 'Parameter/Category', 'Synvisc-One', 'Sallne Control', 'Total', 'Avoiding activities that cause knee pain', '(N=124)', '(N=129)', '(N=253)', 'Exercise or physical therapy', 'Age,', '124', '129', '253', 'Weight loss', 'Mean (SD)', '63.6 (9.6)', '62,5 (9.2)', '63.0 (9.4)', 'Removal of excess fluid from your knee', 'Range', '42,83', '43, 84', '42, 84', 'Drug therapy', 'Sex,', '124', '129', '253', 'Pain relievers such as acetaminophen and narcotics', 'Drugs that reduce inflammation (signs of inflammation are swelling,', 'Female, n (%)', '92 (74%)', '88 (68%)', '180 (71%)', 'pain or redness), such as aspirin and other non-steroldal anti-', 'Race, n', '124', '129', '253', 'inflammatory drugs (NSAIDs, for example ibuprofen and naproxen)', 'Caucasian, n (%)', '118 (95%)', '125 (97%)', '243 (96%)', 'Sterolds that are injected directly into your knee.', 'When should I call my doctor? (Troubleshooting)', 'Non-Caucasian, n (%)', '6 (5%)', '4 (3%)', '10 (4%)', 'If any of the side effects or symptoms described above appear after you', 'Body Mass Index (kg/', '123', '129', '252', 'are given Synvisc-One, or if you have any other problems, you should', 'm\u00b2), n', 'call your doctor.', 'Mean (SD)', '29.1 (4.8)', '29.8 (5.7)', '29.4 (5.4)', 'What dld the clinical studies show?', 'Range', '20.7, 46.0', '19.5, 52.4', '19.5, 52,4', 'A study was conducted in 6 countries outside the United States with 21', 'Prior Corficosteroids In', '123', '130', '253', 'physicians. The patients in the study had mild to moderate knee OA,', 'Target Knee, n\u00b0', 'moderate to severe pain, and did not have sufficient relief of their pain', 'and symptoms with medications taken by mouth.', 'Yes n (%)', '40 (32%)', '31 (24%)', '71 (28%)', '3', '11.', 'r age UU un UL', 'Version Date: 28Mar19']\n\n###\n\n", "completion": "END"}